Adaptin Bio, Inc. Payments of Stock Issuance Costs
Adaptin Bio, Inc. (APTN) reported Payments of Stock Issuance Costs of $152.43 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-28
- Adaptin Bio, Inc. payments of stock issuance costs for the quarter ending 2026-06-30 was $31.27K.
- Adaptin Bio, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $121.16K, a 90.43% decline year-over-year.
- Adaptin Bio, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $417.04K.
- Adaptin Bio, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.27K derived: S-1 6 month − POS AM 3 month · filed 2026-08-28 | $152.43K S-1 · filed 2026-08-28 | $569.47K derived: sum of 3 quarters · filed 2026-08-28 | $569.47K derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | $121.16K POS AM · filed 2026-07-21 | $538.20K derived: sum of 2 quarters · filed 2026-08-28 | $538.20K derived: sum of 3 quarters · filed 2026-08-28 | $538.20K derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | $417.04K derived: S-1 12 month − 10-Q 9 month · filed 2026-08-28 | $417.04K derived: sum of 2 quarters · filed 2026-08-28 | $417.04K derived: sum of 3 quarters · filed 2026-08-28 | $1.68M S-1 · filed 2026-08-28 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − S-1 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-28 | $1.27M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 derived: S-1 6 month − POS AM 3 month · filed 2026-08-28 | $1.27M S-1 · filed 2026-08-28 | ||
| 2025-03-31 | $1.27M POS AM · filed 2026-07-21 | |||
| 2024-12-31 | $193.88K S-1 · filed 2026-08-28 |